Atom Investors LP Akero Therapeutics, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$18.31 - $24.62 $114,950 - $154,564	6,278 Added 42.5%	21,050 $493,000
Q1 2024 May 15, 2024	SELL	$17.76 - $31.18 $549,174 - $964,147	-30,922 Reduced 67.67%	14,772 $373,000
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $302,867 - $1.34 Million	26,614 Added 139.49%	45,694 $1.07 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $785,905 - $996,930	19,080 New	19,080 $965,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.